Breaking News Instant updates and real-time market news.

DHR

Danaher

$124.88

-3.3 (-2.57%)

06:05
04/18/19
04/18
06:05
04/18/19
06:05

Danaher cuts FY19 adj. EPS view to $4.72-$4.80 from $4.75-$4.85, consensus $4.79

  • 18

    Apr

  • 07

    May

  • 29

    May

DHR Danaher
$124.88

-3.3 (-2.57%)

02/27/19
JPMS
02/27/19
NO CHANGE
Target $6
JPMS
Neutral
JPMorgan's Tusa maintains $6 price target on GE after BioPharma sale
JPMorgan analyst Stephen Tusa says there is no change to his $6 price target on General Electric (GE) following the company's BioPharma unit sale to Danaher (DHR). He keeps a Neutral rating on GE, which closed yesterday up 26c to $10.66. While the BioPharma deal "adds incrementally" to the sum-of-the-parts, it also helps to "unmask the underappreciated enterprise cash burn," Tusa tells investors in a research note. He sees the company's cash burn at sustainably in the $2B range now, and a run rate on earnings that "supports a stock well below standing levels." Further, the analyst's "quick initial read" on GE's annual filing suggests "there is more than enough to support" his "standing view on the numbers." Tusa admits, however, that the sale to Danaher is a better after-tax price than he would have expecte, "though certainly not outside the realm of possibilities." However, it leaves a Healthcare asset "that is short on growth," Tusa says, with an implied total enterprise value that is below what he had in his most recent sum-of-the-parts analysis.
02/27/19
EVER
02/27/19
NO CHANGE
Target $130
EVER
Outperform
Danaher, Thermo Fisher now the 'must-owns' in Life Sciences, says Evercore ISI
Evercore ISI analyst Ross Muken said Danaher (DHR) acquired one of the complex's best assets at a highly attractive price with its deal to buy GE Biopharma from GE (GE). After meeting with Danaher management to discuss the deal, Muken said they were "very excited" and he believes his estimates are likely conservative post the meeting. The analyst, who sees several years' worth of highly visible low-double digit EPS growth ahead for Danaher, called the stock, along with Thermo Fisher (TMO), the "must-own equities within the Life Science universe." Muken has an Outperform rating and $130 price target on Danaher shares.
02/28/19
NEED
02/28/19
NO CHANGE
Target $138
NEED
Buy
Danaher price target raised to $138 from $115 at Needham
Needham analyst Stephen Unger raised his price target on Danaher (DHR) to $138 and kept his Buy rating after its $21.4B acquisition of GE's (GE) Biopharma business and its subsequent equity offering. The analyst notes that the changes in his model now call for FY19 EPS forecast reduction to $4.67 from $4.80 from the dilution of the secondary, but FY20 EPS is now seen at $5.64 vs. $5.18 prior on accelerating revenue growth from the deal.
03/04/19
JPMS
03/04/19
NO CHANGE
Target $140
JPMS
Overweight
Danaher price target raised to $140 from $120 at JPMorgan
JPMorgan analyst Tycho Peterson raised his price target for Danaher to $140 following a closer look at the company's acquisition of GE Biopharma. The deal "bears multiple merits," including a meaningful boost to Danaher's long-term organic growth profile through doubled biopharma exposure, significant opportunities for revenue synergies, and an enhanced competitive positioning, Peterson tells investors in a research note. He reiterates an Overweight rating on Danaher.

TODAY'S FREE FLY STORIES

YPF

YPF

$10.18

0.52 (5.38%)

08:15
12/10/19
12/10
08:15
12/10/19
08:15
Downgrade
YPF rating change  »

YPF downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:15
12/10/19
12/10
08:15
12/10/19
08:15
General news
U.S. chain store sales bounced 3.2% in the week ended December 7 »

U.S. chain store sales…

08:15
12/10/19
12/10
08:15
12/10/19
08:15
General news
Productivity and Costs Unit labor costs to be reported at 08:30 »

Productivity and Costs…

08:15
12/10/19
12/10
08:15
12/10/19
08:15
General news
Productivity and Costs Nonfarm productivity to be reported at 08:30 »

Productivity and Costs…

PGTI

PGT Innovations

$14.09

0.125 (0.90%)

08:13
12/10/19
12/10
08:13
12/10/19
08:13
Hot Stocks
PGT Innovations to acquire NewSouth Window Solutions for $92M in cash »

PGT Innovations announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STML

Stemline

$9.91

-0.42 (-4.07%)

08:11
12/10/19
12/10
08:11
12/10/19
08:11
Hot Stocks
Stemline presents Elzonris data at ASH meeting »

Stemline presented data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$70.49

-8.01 (-10.20%)

08:10
12/10/19
12/10
08:10
12/10/19
08:10
Recommendations
Blueprint Medicines analyst commentary  »

Blueprint Medicines price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:10
12/10/19
12/10
08:10
12/10/19
08:10
General news
Treasury Market Outlook: Treasury yields have dipped slightly lower »

Treasury Market Outlook:…

08:10
12/10/19
12/10
08:10
12/10/19
08:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD peaked…

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

08:09
12/10/19
12/10
08:09
12/10/19
08:09
Recommendations
Stitch Fix analyst commentary  »

Stitch Fix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 19

    Dec

DPLO

Diplomat Pharmacy

$3.91

-1.91 (-32.82%)

, UNH

UnitedHealth

$277.56

-2.62 (-0.94%)

08:08
12/10/19
12/10
08:08
12/10/19
08:08
Recommendations
Diplomat Pharmacy, UnitedHealth analyst commentary  »

Deutsche Bank does not…

DPLO

Diplomat Pharmacy

$3.91

-1.91 (-32.82%)

UNH

UnitedHealth

$277.56

-2.62 (-0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXPI

NXP Semiconductors

$117.75

-0.97 (-0.82%)

, MRVL

Marvell

$23.51

-0.67 (-2.77%)

08:08
12/10/19
12/10
08:08
12/10/19
08:08
Recommendations
NXP Semiconductors, Marvell analyst commentary  »

BofA raises NXP…

NXPI

NXP Semiconductors

$117.75

-0.97 (-0.82%)

MRVL

Marvell

$23.51

-0.67 (-2.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 12

    Dec

  • 06

    Jan

EMAN

eMagin

$0.30

-0.0031 (-1.02%)

08:07
12/10/19
12/10
08:07
12/10/19
08:07
Hot Stocks
eMagin announces 'significant' order for military program »

eMagin announced an order…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$59.16

-1.83 (-3.00%)

08:06
12/10/19
12/10
08:06
12/10/19
08:06
Conference/Events
Centene to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LIVX

LiveXLive Media

$2.60

0.28 (12.07%)

08:06
12/10/19
12/10
08:06
12/10/19
08:06
Hot Stocks
LiveXLive Media appoints Garrett English as Chief Creative Officer »

LiveXLive Media announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IR

Ingersoll-Rand

$131.33

-0.36 (-0.27%)

08:05
12/10/19
12/10
08:05
12/10/19
08:05
Hot Stocks
Ingersoll-Rand announces CFO succession plan »

Ingersoll-Rand announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$5.34

0.05 (0.95%)

08:05
12/10/19
12/10
08:05
12/10/19
08:05
Hot Stocks
Arcadia Biosciences announces launch of 'GoodHemp' product line »

Arcadia Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

$163.69

-2.62 (-1.58%)

08:05
12/10/19
12/10
08:05
12/10/19
08:05
Initiation
Workday initiated  »

Workday assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEA

Infrastructure and Energy Alternatives

$3.71

0.015 (0.41%)

08:04
12/10/19
12/10
08:04
12/10/19
08:04
Hot Stocks
Infrastructure and Energy Alternatives announces over $115M in project awards »

Infrastructure and Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGE

A.G. Edwards

$1.56

0.295 (23.32%)

, LCTX

Lineage Cell Therapeutics

$0.75

-0.0538 (-6.74%)

08:04
12/10/19
12/10
08:04
12/10/19
08:04
Hot Stocks
A.G. Edwards, Lineage Cell Therapeutics issued U.S. patent »

AgeX Therapeutics (AGE)…

AGE

A.G. Edwards

$1.56

0.295 (23.32%)

LCTX

Lineage Cell Therapeutics

$0.75

-0.0538 (-6.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Dec

AGCO

Agco

$75.99

-0.58 (-0.76%)

08:04
12/10/19
12/10
08:04
12/10/19
08:04
Conference/Events
Agco to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BLDP

Ballard Power

$6.31

-0.24 (-3.66%)

08:03
12/10/19
12/10
08:03
12/10/19
08:03
Hot Stocks
Ballard Power signs agreement with Hydrogene de France »

Ballard Power Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPHI

Inphi

$69.15

-1.035 (-1.47%)

08:02
12/10/19
12/10
08:02
12/10/19
08:02
Recommendations
Inphi analyst commentary  »

Inphi should be bought at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNSP

CNS Pharmaceuticals

$3.97

-0.01 (-0.25%)

08:02
12/10/19
12/10
08:02
12/10/19
08:02
Hot Stocks
CNS Pharmaceuticals receives positive FDA Pre-ING guidance for Berubicin »

CNS Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOCS

Focus Financial Partners

$26.84

-0.35 (-1.29%)

08:02
12/10/19
12/10
08:02
12/10/19
08:02
Initiation
Focus Financial Partners initiated  »

Jefferies starts Focus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.